Op-Ed: An Easy Cell

January 29, 2007

In the future, look for the first biotech firm to derive an effective AFS cell therapy to enter into an exclusive relationship with a storage banking facility. Cryo-Cell already has one such arrangement with the Plureon Corporation in its storage of placental ASC. (The American)